artemisinin has been researched along with Metastase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efferth, T; Michaelsen, FW; Saeed, ME; Schwarzkopf, J | 1 |
| Chen, Z; Gao, J; Guo, Y; Li, G; Wang, J; Xie, Q; Zhang, B; Zhu, B | 1 |
2 other study(ies) available for artemisinin and Metastase
| Article | Year |
|---|---|
Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma.
Topics: Aged, 80 and over; Artemisia annua; Artemisinins; Artesunate; Biomarkers, Tumor; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms | 2015 |
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Carcinoma, Lewis Lung; Female; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Survival Rate; Vascular Endothelial Growth Factor C | 2008 |